Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorders. In addition, the company provides education and children's, and adult care services. As of March 31, 2021, it operated a network of 228 behavioral healthcare facilities with approximately 10,000 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
IPO Year:
Exchange: NASDAQ
Website: acadiahealthcare.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/25/2024 | $70.00 | Sell → Hold | Deutsche Bank |
3/6/2024 | $100.00 | Overweight | Barclays |
4/21/2023 | $83.00 | Neutral | Cantor Fitzgerald |
4/20/2023 | $75.00 → $63.00 | Hold → Sell | Deutsche Bank |
12/12/2022 | $90.00 → $95.00 | Hold → Buy | Loop Capital |
6/17/2022 | $72.00 | Hold | Loop Capital |
3/2/2022 | $74.00 → $78.00 | Outperform | Credit Suisse |
3/1/2022 | $83.00 → $80.00 | Outperform | SVB Leerink |
11/1/2021 | $68.00 → $69.00 | Outperform | Credit Suisse |
9/27/2021 | $85.00 | Outperform | SVB Leerink |
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
3 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the opening of its newest acute care hospital, Agave Ridge Behavioral Hospital, located at 3322 S. Ellsworth Road, in Mesa, Arizona. A ribbon-cutting ceremony was held today to mark its grand opening. The first patient admissions are expected to follow in the coming days as the hospital completes its final preparations to provide care for those in need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411986178/en/Acadia Healthcare hosts ribbon-cutting ceremony on April 11, 2024, for its new behavioral health hospital in Mesa, Arizona. The new hospital, named Agave R
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Stephanie Eken as the Company's new chief medical officer. Dr. Eken is a psychiatrist with more than two decades of experience across the spectrum of behavioral health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404108920/en/Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire) "Acadia is thrilled to welcome Dr. Eken as our new chief medical officer," said Chris Hunter, Chief Executive Officer of Acadia Healthcare. "Her experience and expertise will help Acadia set the standard for care across the i
Henry Ford Health, one of the nation's premier academic and integrated health systems, and Acadia Healthcare, the nation's largest stand-alone behavioral healthcare company, today announced the appointment of Emily Sexton as Chief Executive Officer of Henry Ford Behavioral Health Hospital, the new 192-bed inpatient behavioral health hospital being built through a joint venture partnership between Henry Ford and Acadia in West Bloomfield, Michigan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220715559/en/Henry Ford Health and Acadia Healthcare announced the appointment of Emily Sexton as Chief Executive Officer of Henry For
Dixon Brings Over 25 Years of Financial and Healthcare Experience David Duckworth to Step Down After 12 Years as Acadia's CFO Larry Harrod, EVP, Finance Announces Retirement; Tim Sides to Assume Responsibilities Company Reaffirms Full Year Fiscal 2023 Guidance Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia" or the "Company") today announced Heather Dixon has been appointed Chief Financial Officer (CFO), effective July 10, 2023. Dixon succeeds David Duckworth, who has decided to step down after more than a decade as the Company's CFO. Duckworth will work closely with Dixon in an advisory capacity to support a smooth transition of responsibilities. This press release features
Dr. Khan brings 20 years of healthcare and provider-based experience to this role Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Nasser Khan, M.D., as Operations Group President for its Comprehensive Treatment Center (CTC) business. Dr. Khan will oversee Acadia's network of 145 CTC facilities and associated services. He joined Acadia on September 6th following the retirement of the CTC business' previous group president. Dr. Khan will report to John Hollinsworth, EVP Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220914005293/en/Acadia Healthcare Company appointed Dr. Nasser Khan
The Board of Directors of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that Debbie Osteen will retire as CEO. Ms. Osteen will continue to serve on Acadia's Board of Directors and will assist in the selection and transition of the new CEO. It is anticipated that Ms. Osteen's retirement will be effective on January 31, 2022. Reeve Waud, Chairman of Acadia's Board of Directors, said, "Debbie has done an outstanding job as Acadia's CEO with the support of a strong senior team, and the Board could not be more pleased with the Company's progress under Debbie's leadership. We are very appreciative of her efforts in leading the Company through a period of significant progress and
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
Investor-owned psychiatric hospital chains increasingly operate under nonprofit brands, a strategy that has raised eyebrows among industry analysts and healthcare advocates. Universal Health Services (NYSE:UHS) and Acadia Healthcare Company, Inc. (NASDAQ:ACHC) are prominent players. STAT News’ investigation reveals that a Columbus Police sergeant called for action against Mt. Carmel Behavioral Health, run by Acadia Healthcare, highlighting a series of alarming incidents at the psychiatric hospital. The sergeant’s February letter outlines a disturbing pattern of violence, prompting concerns about patient and staff safety. Over the past six months, the hospital has witnessed over 2
Cantor Fitzgerald analyst Sarah James reiterates Acadia Healthcare Co (NASDAQ:ACHC) with a Neutral and maintains $90 price target.
Cantor Fitzgerald analyst Sarah James reiterates Acadia Healthcare Co (NASDAQ:ACHC) with a Neutral and maintains $90 price target.
Acadia Healthcare Co (NASDAQ:ACHC) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 3 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 1 2 1 0 0 3M Ago 1 1 1 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $85.62, a high estimate of $94.00, and a low estimate of $70.00. Highlighting a 9.87% decrea
Cantor Fitzgerald analyst Sarah James reiterates Acadia Healthcare Co (NASDAQ:ACHC) with a Neutral and maintains $90 price target.
Acadia Healthcare Co's (NYSE:ACHC) short percent of float has risen 10.28% since its last report. The company recently reported that it has 3.61 million shares sold short, which is 3.97% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.32 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short i
RBC Capital analyst Ben Hendrix reiterates Acadia Healthcare Co (NASDAQ:ACHC) with a Outperform and maintains $94 price target.
Across the recent three months, 12 analysts have shared their insights on Acadia Healthcare Co (NASDAQ:ACHC), expressing a variety of opinions spanning from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 5 4 0 0 Last 30D 1 0 0 0 0 1M Ago 1 2 2 0 0 2M Ago 0 0 0 0 0 3M Ago 1 3 2 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $89.33, a high estimate of $102.
TD Cowen analyst Gary Taylor maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Buy and lowers the price target from $101 to $91.
Barclays analyst Andrew Mok maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Overweight and lowers the price target from $91 to $89.
Methodist Jennie Edmundson Hospital and Acadia Healthcare Company held a groundbreaking ceremony today for a state-of-the-art behavioral health hospital serving western Iowa and eastern Nebraska residents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240827527624/en/Methodist Health and Acadia Healthcare break ground on the construction of the new Methodist Jennie Edmundson Behavioral Health Hospital in Council Bluffs, Iowa, with an anticipated opening in 2026. (Photo: Daniel Johnson/Methodist Health System) The event occurred on the site of the future hospital at 3620 S. 24th St. in Council Bluffs, Iowa, and celebrated the pr
Provides Updated Guidance for 2024 Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Highlights Revenue totaled $796.0 million, an increase of 8.8% over the second quarter of 2023 Same facility revenue increased 8.3% compared with the second quarter of 2023, including an increase in revenue per patient day of 5.6% and an increase in patient days of 2.6% Net income attributable to Acadia totaled $78.5 million, or $0.85 per diluted share Adjusted income attributable to Acadia totaled $83.6 million, or $0.91 per diluted share Adjusted EBITDA totaled $187.6 million, an incr
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its second quarter 2024 results on Wednesday, July 31, 2024, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, August 1, 2024. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2024, Acadia operated a network of 256 behavioral healthcare facilities
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that the Company will participate in the 2024 Leerink Partners Healthcare Crossroads Conference, May 28 – 30, 2024, at the Omni Barton Creek Resort & Spa in Austin, Texas. In connection with the conference, there will be an online webcast of the Company's presentation available on the Company's website starting at 9:20 a.m. Central Time on Wednesday, May 29, 2024. The live webcast of the presentation will be available on the Company's website, www.acadiahealthcare.com, by clicking on the "Investors" link. A replay of the presentation will also be available on the Company's website for 30 days. About Acadia Acadia is a lea
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that the Company will participate in the BofA Securities 2024 Health Care Conference, May 14-16, 2024, in Las Vegas, Nevada. In connection with the conference, there will be an online webcast of the Company's presentation available on the Company's website starting at 6:20 p.m. Central Time / 4:20 p.m. Pacific Time on Tuesday, May 14th, 2024. The live webcast of the presentation will be available on the Company's website, www.acadiahealthcare.com, by clicking on the "Investors" link. A replay of the presentation will also be available on the Company's website for 30 days. About Acadia Acadia is a leading provider of behav
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2024. First Quarter Highlights Revenue totaled $768.1 million, an increase of 9.1% over the first quarter of 2023 Same facility revenue increased 9.2% compared with the first quarter of 2023, including an increase in revenue per patient day of 6.9% and an increase in patient days of 2.2% Net income attributable to Acadia totaled $76.4 million, or $0.83 per diluted share Adjusted income attributable to Acadia totaled $77.3 million, or $0.84 per diluted share Adjusted EBITDA totaled $173.9 million, an increase of 14.9% over the first quarter of 2023 Adjuste
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the opening of its newest acute care hospital, Agave Ridge Behavioral Hospital, located at 3322 S. Ellsworth Road, in Mesa, Arizona. A ribbon-cutting ceremony was held today to mark its grand opening. The first patient admissions are expected to follow in the coming days as the hospital completes its final preparations to provide care for those in need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411986178/en/Acadia Healthcare hosts ribbon-cutting ceremony on April 11, 2024, for its new behavioral health hospital in Mesa, Arizona. The new hospital, named Agave R
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Stephanie Eken as the Company's new chief medical officer. Dr. Eken is a psychiatrist with more than two decades of experience across the spectrum of behavioral health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404108920/en/Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire) "Acadia is thrilled to welcome Dr. Eken as our new chief medical officer," said Chris Hunter, Chief Executive Officer of Acadia Healthcare. "Her experience and expertise will help Acadia set the standard for care across the i
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its first quarter 2024 results on Wednesday, May 1, 2024, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, May 2, 2024. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2023, Acadia operated a network of 253 behavioral healthcare facilities wi
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced a collaboration with Uber Health (NYSE:UBER). The two companies are coming together to improve access to life-saving behavioral health care and addiction treatment by providing patients access to transportation, so they can begin treatment quickly and efficiently. The initial focus is on Acadia's national network of Comprehensive Treatment Centers (CTCs). CTCs provide medication-assisted treatment (MAT) in combination with counseling and behavioral therapies for those who are struggling with opioid addiction. Launching with 19 facilities across several states, Acadia and Uber Health plan to roll out the program to more faciliti
10-Q - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
10-Q - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
ARS - Acadia Healthcare Company, Inc. (0001520697) (Filer)
DEFA14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)
DEF 14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)
PRE 14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)
144 - Acadia Healthcare Company, Inc. (0001520697) (Subject)
Provides Updated Guidance for 2024 Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Highlights Revenue totaled $796.0 million, an increase of 8.8% over the second quarter of 2023 Same facility revenue increased 8.3% compared with the second quarter of 2023, including an increase in revenue per patient day of 5.6% and an increase in patient days of 2.6% Net income attributable to Acadia totaled $78.5 million, or $0.85 per diluted share Adjusted income attributable to Acadia totaled $83.6 million, or $0.91 per diluted share Adjusted EBITDA totaled $187.6 million, an incr
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its second quarter 2024 results on Wednesday, July 31, 2024, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, August 1, 2024. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2024, Acadia operated a network of 256 behavioral healthcare facilities
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2024. First Quarter Highlights Revenue totaled $768.1 million, an increase of 9.1% over the first quarter of 2023 Same facility revenue increased 9.2% compared with the first quarter of 2023, including an increase in revenue per patient day of 6.9% and an increase in patient days of 2.2% Net income attributable to Acadia totaled $76.4 million, or $0.83 per diluted share Adjusted income attributable to Acadia totaled $77.3 million, or $0.84 per diluted share Adjusted EBITDA totaled $173.9 million, an increase of 14.9% over the first quarter of 2023 Adjuste
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its first quarter 2024 results on Wednesday, May 1, 2024, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, May 2, 2024. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2023, Acadia operated a network of 253 behavioral healthcare facilities wi
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it has recently completed the acquisitions of three comprehensive treatment centers ("CTC") in North Carolina. Two of the locations, rebranded as Raleigh Comprehensive Treatment Center and Greenville Comprehensive Treatment Center, are located in Raleigh, North Carolina, and Greenville, North Carolina, respectively. The third acquired location, rebranded as Hillsborough Comprehensive Treatment Center, in Hillsborough, North Carolina, serves residents in communities from Durham to Burlington. With these additions, Acadia now operates 10 CTC locations in North Carolina and 160 locations in 32 states across the country. "
Company Provides Full Year and First Quarter 2024 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter Highlights Revenue totaled $742.8 million, an increase of 10.0% over the fourth quarter of 2022 Same facility revenue increased 10.3% compared with the fourth quarter of 2022, including an increase in revenue per patient day of 7.1% and an increase in patient days of 2.9% Net income attributable to Acadia totaled $57.7 million, or $0.63 per diluted share Adjusted income attributable to Acadia was $78.3 million, or $0.85 per diluted share, e
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its fourth quarter and year-end 2023 results on Tuesday, February 27, 2024, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 8:00 a.m. ET on Wednesday, February 28, 2024. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of September 30, 2023, Acadia operated a network of 253 behaviora
Same Facility Revenue Increases 13% Acadia Healthcare Company, Inc. ("Acadia") (NASDAQ:ACHC) today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights Revenue totaled $750.3 million, an increase of 12.5% over the third quarter of 2022 Same facility revenue increased 13.0% compared with the third quarter of 2022, including an increase in revenue per patient day of 6.6% and an increase in patient days of 6.0% Net loss attributable to Acadia totaled $217.7 million, or $2.39 per diluted share, including the impact of legal settlements expense of $394.2 million, less expected tax benefits Adjusted income attributable to Acadia was
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its third quarter 2023 results on Thursday, November 2, 2023, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Friday, November 3, 2023. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of September 30, 2023, Acadia operated a network of 253 behavioral healthcare facilit
Company Signs Definitive Agreement for Acquisition of Specialty Provider Acadia Healthcare Company, Inc. ("Acadia") (NASDAQ:ACHC) today announced financial results for the second quarter ended June 30, 2023. Second Quarter and Recent Highlights Revenue totaled $731.3 million, an increase of 12.2% over the second quarter of 2022 Same facility revenue increased 11.4% compared with the second quarter of 2022, including an increase in revenue per patient day of 6.1% and an increase in patient days of 4.9% Net income attributable to Acadia totaled $72.3 million, or $0.79 per diluted share, and adjusted income from continuing operations attributable to Acadia totaled $84.7 million, o
Deutsche Bank upgraded Acadia Healthcare from Sell to Hold and set a new price target of $70.00
Barclays initiated coverage of Acadia Healthcare with a rating of Overweight and set a new price target of $100.00
Cantor Fitzgerald initiated coverage of Acadia Healthcare with a rating of Neutral and set a new price target of $83.00
Deutsche Bank downgraded Acadia Healthcare from Hold to Sell and set a new price target of $63.00 from $75.00 previously
Loop Capital upgraded Acadia Healthcare from Hold to Buy and set a new price target of $95.00 from $90.00 previously
Loop Capital initiated coverage of Acadia Healthcare with a rating of Hold and set a new price target of $72.00
Credit Suisse reiterated coverage of Acadia Healthcare Co with a rating of Outperform and set a new price target of $78.00 from $74.00 previously
SVB Leerink reiterated coverage of Acadia Healthcare Co with a rating of Outperform and set a new price target of $80.00 from $83.00 previously
Credit Suisse reiterated coverage of Acadia Healthcare Co with a rating of Outperform and set a new price target of $69.00 from $68.00 previously
SVB Leerink initiated coverage of Acadia Healthcare Co with a rating of Outperform and set a new price target of $85.00